Evidence map›Paper›PMID 38291373›Full record

ArticleBMC cancer2024

Physician-brief advice for promoting smoking cessation among cancer patients on treatment in low and middle-income countries: a scoping review.

Olayinka Stephen Ilesanmi, Babalola Faseru, Aanuoluwapo Adeyimika Afolabi, Olukemi Odukoya, Olalekan Ayo-Yusuf, Folahanmi Akinsolu, Akindele Olupelumi Adebiyi, William K Evans

Open access · goldAbstract readScoping Review
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Olayinka Stephen IlesanmiAfrica Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. ileolasteve@yahoo.co.uk.
Babalola FaseruDepartment of Population Health, University of Kansas Medical Center, Kansas City, US.
Aanuoluwapo Adeyimika AfolabiDepartment of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
Olukemi OdukoyaDepartment of Community Health and Primary Care, College of Medicine, University of Lagos, Lagos, Nigeria.
Olalekan Ayo-YusufSchool of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.
Folahanmi AkinsoluDepartment of Public Health, Lead City University, Ibadan, Nigeria.
Akindele Olupelumi AdebiyiDepartment of Community Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
William K EvansDepartment of Oncology, McMaster University, Hamilton, ON, Canada.
University of Ibadan · NGAfrica Centres for Disease Control and Prevention · ETLead City University · NGMcMaster University · CAUniversity of Kansas Medical Center · USUniversity of Lagos · NGUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPhysician-brief advice has been utilized in high-income countries to promote smoking cessation among cancer patients. Empirical evidence on its effectiveness among cancer patients in low and middle-income countries (LMICs) is lacking. The gap could be due to inadequate training, and competing healthcare priorities, leading to insufficient implementation of targeted smoking cessation interventions in oncology settings. We undertook this scoping review to determine if physician-brief advice is effective in promoting smoking cessation among cancer patients in LMICs.

methodsWe conducted a literature search of all relevant articles across five databases: Cochrane Central Register of Controlled Trials, Cochrane Library (Tobacco Addiction Group trials), World Conference on Lung Cancer proceedings, PubMed, and Google Scholar up to November 2023, using pre-defined inclusion criteria and keywords. The study population was cancer survivors in LMICs, the intervention was smoking cessation advice by a physician in a clinic or oncology center during a consultation, and the outcome was the effect of smoking cessation programs in discontinuing smoking among cancer survivors in LMICs.

resultsOverall, out of every 10 cancer patients in LMICs, about seven were smokers, and one-half had received physician-brief advice for smoking cessation. Physician-brief advice was more likely to be delivered to patients with smoking-related cancer (Cohen's d = 0.396). This means that there is a noticeable difference between patients with smoking-related cancer compared to those with cancer unrelated to smoking. Smoking cessation failure was due to the inability to cope with the symptoms of withdrawal, missed smoking cessation clinic visits, mental health disorders, limited time and resources, and minimal patient-physician contact.

conclusionThere is very little literature on the frequency of use or the efficacy of physician-brief advice on smoking cessation in LMICs. The literature suggests that cancer patients in LMICs have low self-efficacy to quit smoking, and smoking cessation is rarely part of cancer care in LMICs. Physicians in LMICs should be trained to use motivational messages and good counseling techniques to improve smoking cessation among cancer patients. Policymakers should allocate the resources to implement physician-brief advice and design training programs for physicians focusing on physician-brief advice tailored to cancer patients.

Indexed as

NeoplasmsPhysiciansSmoking CessationCrisis InterventionDeveloping CountriesHumansPractice Patterns, Physicians'SmokingSmoking PreventionLow and middle-income countriesPhysician-brief advicePhysiciansSmokingSmoking cessation

Identifiers

PMID38291373
PMCPMC10826229
OpenAlexW4391352998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.